Where the ethical action is
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- ‘A sword of Damocles’: patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study
- RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study
- Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial
- Where the ethical action also is: a response to Hardman and Hutchinson
- High serum soluble CD200 levels in patients with autosomal dominant polycystic kidney disease
- High serum soluble α-Klotho levels in patients with autosomal dominant polycystic kidney disease
- Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
- New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol
- Mean Platelet Volume and Its Relation With Arterial Stiffness in Patients With Normotensive Polycystic Kidney Disease
- Autosomal dominant polycystic kidney disease unlinked to thePKD1 and PKD2loci presenting as familial cerebral aneurysm